awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745427-BC33D392-5FA9-4854-9D1B-F818C2058F9A
Q26745427-BC33D392-5FA9-4854-9D1B-F818C2058F9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745427-BC33D392-5FA9-4854-9D1B-F818C2058F9A
Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer
P2860
Q26745427-BC33D392-5FA9-4854-9D1B-F818C2058F9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745427-BC33D392-5FA9-4854-9D1B-F818C2058F9A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc8587a3cbbdac24a4d772f3fa40a6bc1cebadc9
P2860
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.